Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay.
about
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancerDecentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis testLuminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signalingClinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer.The innovative evolution of cancer gene and cellular therapies.Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine.The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical DecisionsBreast Cancer Update 2014 - Focus on the Patient and the Tumour.30th german cancer congress, 22nd-25th february 2012, berlin.Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-studyAn international comparability study on quantification of mRNA gene expression ratios: CCQM-P103.1.From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.Breast Cancer Biomarkers: Utility in Clinical Practice.Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.Indications for prognostic gene expression profiling in early breast cancer.A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.Biomarker assessment and molecular testing for prognostication in breast cancer.HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancerMammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancer.Developing a new generation of breast cancer clinical gene expression testsBiomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.[Molecular pathology for breast cancer: Importance of the gene expression profile].[Gene expression analysis in breast cancer. A new diagnostic tool in pathology].RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.
P2860
Q21089802-47AE34C5-B918-420B-A928-58970B3EE657Q21261272-51562D7F-EA0D-45AE-9AFF-5B4352840D4CQ31132241-653E2154-72CE-4A39-A5EB-FA18B424FA39Q33827057-3866D160-97D8-46BB-8F29-2B639388D66AQ34271033-9A20D6EB-8FCE-4A52-A1FC-E9D506CB956DQ34325544-95139F0D-65C0-4E22-901D-BBE33C13B91AQ34657656-1D421ADA-2851-414B-A983-AB73881E14C7Q34797928-BC0711AD-08EE-4F88-B46E-44357D2B5586Q35180940-CBFB3087-AC3C-4A92-9EEC-50DD4756281EQ35883058-73BB0EC3-2F2D-4DF8-A7B7-57575C841145Q36598709-44F64DCD-6B0D-4706-8756-E1E6A910299BQ36615742-281E502B-A871-4B5E-BEB8-55FD88A53DA9Q36678505-4C9047D6-38E7-4D45-8319-0C675DAE1327Q37000029-10F75207-BACF-4F89-ACFC-DA54A5B8C320Q37214217-C29E8BE3-A39F-4E26-B032-23BDFAE72F26Q37383276-D4447AD1-32FE-4115-90C6-0D2688C9AB11Q37441159-5168A12D-4054-45CD-90C3-1EE30FC49BCAQ37591446-9E9C028E-2CA6-4E39-98A9-A8291C787141Q38089481-6F394122-EA04-4C3F-9006-3B1E8D84ADF8Q38451798-4654D574-33DE-4DBB-B5F0-897FABE54FCCQ38682197-1CB0E9C5-8E7D-453E-BFF0-DA0D59409C1AQ38696790-356D3B2E-BFDA-4C90-8504-65BE1D5BD860Q38710164-F81135D8-8578-4EE8-AAA4-D7D502B0DD95Q39187437-14E0F76D-BA93-4868-B14C-6A66DB5E54EAQ41495744-D7CD318C-BAB9-4007-AAE6-C2660692F1FCQ41545259-08D76512-B753-40D9-B206-3D00EE0F18BBQ41608998-15FD84CC-CE62-4F40-BDEE-3DE34D59A6E0Q42737349-CFC6C854-2446-4B87-B0A6-BE827D1FE0D4Q48353102-212DDC80-45BE-48E9-91F2-A1DB23DF33E5Q52868166-F662492E-89C0-4BC0-B2FE-BD22978107E9Q52882864-D4A23804-7A70-48A2-BA5E-17F9CA30C0C0Q52886164-668EBF0D-48B8-4A47-BE36-CF9F0EDD2E40
P2860
Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Decentral gene expression anal ...... ram for the EndoPredict assay.
@ast
Decentral gene expression anal ...... ram for the EndoPredict assay.
@en
type
label
Decentral gene expression anal ...... ram for the EndoPredict assay.
@ast
Decentral gene expression anal ...... ram for the EndoPredict assay.
@en
prefLabel
Decentral gene expression anal ...... ram for the EndoPredict assay.
@ast
Decentral gene expression anal ...... ram for the EndoPredict assay.
@en
P2093
P2860
P50
P1433
P1476
Decentral gene expression anal ...... ram for the EndoPredict assay.
@en
P2093
Carsten Denkert
Christoph Petry
Frank Tiecke
Gudrun Schlake
Hans-Heinrich Kreipe
Heinz Höfler
Holger Moch
Judith Prinzler
Karsten E Weber
Katja Specht
P2860
P2888
P304
P356
10.1007/S00428-012-1204-4
P577
2012-02-28T00:00:00Z